医药生物行业周报:美股big pharma 2024年报:关注业绩表现、指引及2025年重点催化剂事件
“Big enough to survive and small enough to care — we can do it!”
public-cloud-in-china-big-challenges-big-upside
商业化平台价值凸显,向生态型Big Pharma迈进
Big Ideas 2024(中文编译版)
–Big milestone achieved with fruquintinib successfully approved by US FDA
创仿结合,开启Big Pharma国际化新征程
Australia’s Carbon Market Hits the Big Leagues
The big shift: Moving commercial vehicle OEMs to centralized E/E and Software
深度研究报告:Betta(贝达):A Big Alpha